2026 Australian Chemical Manufacturing: M&A Overview

By Morgan Business Sales | Updated August 2026

Sector Overview

Chemical manufacturing is one of the more fragmented and technically specialised corners of Australian industry. It stretches from large-scale industrial gas and basic chemical production through to small formulators making cleaning products, coatings, adhesives or agricultural inputs in a single-site facility. Chemistry Australia, the industry's peak body, puts the sector's total economic contribution at roughly A$48–49 billion in GDP terms, supporting close to 70,000 direct jobs and around 240,000 jobs across the wider economy. Within that broader figure sit thousands of small and mid-sized manufacturers and distributors — the segment Morgan Business Sales works with most often.

The subsegments behave quite differently from one another. Basic inorganic and industrial gas manufacturing are capital-intensive and concentrated among a small number of larger players. Paints and coatings, adhesives and sealants, and cleaning and personal care manufacturing are more fragmented, with hundreds of established regional and specialist operators. Agricultural chemicals and fertilisers track the farming cycle closely, while chemical distribution and wholesaling — a sizeable A$17 billion-plus category on its own — is where much of the mid-market deal activity in this report actually occurs, since distributors are easier to scale through acquisition than manufacturing plants.

For an owner, this fragmentation cuts both ways. It means there is rarely a single dominant player who can simply buy up the market, so a well-run regional or specialist business retains real independent value. It also means buyers assess each opportunity on its own terms — formulation knowledge, registrations, customer relationships, supply security and site condition — rather than applying one blanket industry multiple. The businesses that attract the strongest interest are usually the ones that can show a defensible niche, a diversified customer base and management that does not depend entirely on one founder.

Listed consolidators including DGL Group, Redox, Elders and Ridley Corporation have been consistently active in bolt-on acquisitions across distribution, logistics and agricultural inputs, while global distributors such as Azelis and IMCD have used Australian acquisitions to expand their regional footprint. This ongoing activity is a useful signal that buyer appetite for capable, compliant chemical businesses exists across market cycles — even in a period where some larger private equity investors have become more selective about the sector globally.

ANZSIC Classification

These classifications help place your business in the right part of the market and identify the owners, operators and buyers most relevant to it. Many businesses span more than one code, so the most useful classification is the activity that generates most of the revenue.

27 Verified M&A Transactions (2021–2026)

This table covers 22 core mid-market transactions under A$50M and five larger deals noted for context. It is not a valuation formula. It is a practical view of the businesses buyers have actually acquired, the capabilities they sought and the prices disclosed where available. All values are in Australian dollars unless stated otherwise.

Transaction Commentary

DGL Group — Disciplined Bolt-On Consolidation in Chemical Distribution and Logistics

DGL Group has been the most consistently active acquirer in Australian chemical distribution and logistics over the past five years, completing around 30 transactions by FY25, including Aquapac, RLA Polymers, Aquadex, Flexichem Australia, Enlog Pacific and Australian Petro Chemical Storage. What makes DGL's activity especially useful for a business owner is that, as a listed company, it discloses more pricing detail than almost any other acquirer in the sector — its bolt-on deals have priced at 2.5x to 5.4x EBITDA, mostly clustered toward the lower end for smaller distribution and logistics assets. DGL's FY25 results showed a more cautious "transitional year" with underlying EBITDA down and acquisitions paused for now, a reminder that even active consolidators periodically step back to digest what they have already bought. For an owner in chemical distribution or logistics, the lesson is that scale, hazardous-goods handling capability and clean regulatory compliance are the features that make a business easy for a buyer like DGL to bolt on quickly.

Azelis and IMCD — Global Distributors Building an Australian Footprint

Two of the world's largest specialty chemical distribution groups have used Australian acquisitions to expand their regional presence. Belgium-based Azelis acquired Chemiplas Agencies, a specialty chemicals and plastics distributor with more than 100 staff and 1,900 customers across Australia, New Zealand and the Pacific, and separately acquired Agspec Australia to strengthen its position in agricultural and horticultural chemicals. Netherlands-based IMCD acquired ResChem Technologies, a Sydney-based resins, additives and pigments distributor serving the coatings, adhesives and construction sectors. Neither transaction disclosed a price, which is typical of these global strategic buyers, but both show a consistent pattern: they value businesses with established supplier relationships, technical formulation knowledge and a loyal customer base built over many years. For an owner running a specialty distribution business, being an attractive target for a global platform often comes down to demonstrating exclusive or long-standing supplier agreements and deep technical customer relationships that a buyer cannot quickly replicate.

Redox and IXOM — Established Distributors Adding Complementary Product Lines

Redox, one of Australia's largest chemical distributors by revenue, and IXOM, a major industrial and water-treatment chemicals business, have both grown through smaller bolt-on acquisitions that add complementary products rather than entirely new business lines. Redox acquired Molekulis, a Brisbane-based transformer and specialty oils distributor with around $27M in revenue, while IXOM added Australian Botanical Products (essential oils and fragrance ingredients) and expanded its diesel exhaust fluid range through the SCR acquisition. These deals show that established distributors are often the most realistic buyer for a smaller specialty business — not because they need the revenue, but because they want the product range, supplier relationships or customer list that comes with it. An owner considering this kind of buyer should be ready to explain clearly how the business's products and customers would slot into a larger distribution network, and what unique supplier or technical relationships underpin the business.

Private Equity Moving Into Personal Care and Cleaning Manufacturing

Private equity has shown consistent interest in Australian personal care and cleaning product manufacturing. ShawKwei & Partners acquired Rauxel, a beauty and healthcare products manufacturer later rebranded Icons | Rauxel, and Glow Capital Partners took a majority stake in Delta Laboratories, a 40-year-old TGA-registered contract manufacturer of cosmetics, sunscreen and skincare products based in Somersby, NSW. Fortitude Investment Partners' 2026 acquisition of Richard Jay, a 90-staff laundry equipment and cleaning chemicals manufacturer serving healthcare, hospitality and mining customers, follows the same pattern. These buyers are typically looking for a business with genuine manufacturing or formulation capability, established regulatory registrations (such as TGA listing) and a diversified customer base across sectors. For an owner in personal care or cleaning manufacturing, the practical takeaway is that private equity buyers value predictable, well-documented earnings over rapid growth — cash-generative businesses with clean compliance records are more attractive than growth stories with thin margins.

Christeyns and HydroChem — Strategic Joint Ventures With Established Family Businesses

Not every transaction in this dataset is a straightforward acquisition. Belgian hygiene group Christeyns entered a majority-stake joint venture with True Blue Chemicals, a NSW cleaning and hygiene solutions manufacturer established in 1986 that serves healthcare, hospitality and education customers, while WA-based HydroChem joined forces with Environex, another long-established family-owned chemical manufacturer, to create a combined entity with more than $80M in turnover across four plants. These structures let an owner retain some involvement and upside while bringing in a larger partner's capital, systems or distribution reach. For an owner not ready for a full and final exit, a joint venture or majority-stake partnership with a strategic buyer can be a practical middle path — but it requires the business to have a strong enough standalone track record that a partner is willing to structure the deal this way rather than simply making a full-acquisition offer.

Elders and Ridley Corporation — Consolidation in Agricultural Chemical Distribution

The largest transactions in this dataset both involve agricultural chemical and fertiliser distribution consolidation. Elders acquired Delta Agribusiness for $475M enterprise value, adding 68 locations of farm inputs, crop protection, seeds and animal health distribution, while Ridley Corporation acquired Incitec Pivot's fertiliser distribution business for $381M upfront, priced at roughly 4.2x to 5.0x EBITDA — the cleanest disclosed mid-to-large agricultural distribution benchmark in this entire report. Both deals sit well above the typical Morgan Business Sales mid-market range, but they are useful context: they show that scaled, well-run agricultural distribution businesses with established grower relationships and multi-site networks continue to command solid strategic buyer interest. For a smaller agricultural chemical distributor, the practical read is that the demand exists across the whole size spectrum, and buyers value networks of grower relationships, registered product lines and reliable regional coverage over almost anything else.

Valuation Benchmarks by Subsegment

A multiple is only a shorthand for risk, quality and scale. The table below uses a conservative tiered approach based on EBITDA — operating profit before interest, tax, depreciation and amortisation — because a small formulator, a stable $2M-profit specialist and a national distribution platform should not be valued in the same way.

A number of real Australian deals help illustrate where mid-market pricing lands. DGL Group's chemical logistics and storage bolt-ons — Australian Petro Chemical Storage and Enlog Pacific — priced at 2.5x EBITDA, with the APCS deal moving to 3.7x once accounting for lease treatment. RLA Polymers, a synthetic latex and adhesives manufacturer, went for 4.1x normalised EBITDA. At the higher end of the mid-market evidence, Ridley Corporation's acquisition of Incitec Pivot's fertiliser distribution business priced at roughly 4.2x to 5.0x EBITDA on a business generating $72M-$86M in earnings — considerably larger than a typical Morgan Business Sales listing, but a clean and credible anchor for agricultural chemical distribution pricing.

The central message is straightforward. Verified mid-market transactions in Australian chemical manufacturing and distribution cluster around 2.5x-6.5x EBITDA, closely matching the pattern seen in adjacent Australian industrial sectors. The lower end is common for smaller, less differentiated distribution and logistics businesses. The upper end is associated with genuine manufacturing capability, diversified customers, established registrations and recurring B2B relationships. Double-digit multiples belong to large, branded, platform-scale businesses such as national distribution platforms or listed personal-care manufacturers — not the typical $2M-$50M revenue mid-market operator. Owners should use the range as a planning guide, not a promise.

Demand Drivers

Sovereign manufacturing and critical minerals policy

The $15 billion National Reconstruction Fund is directing capital toward local manufacturing and value-add resources processing, which relies heavily on industrial chemical inputs such as acids, solvents and reagents. A concrete example is the Fund's $75 million cornerstone investment in Gladstone-based Alpha HPA, which uses nitric-acid leaching and solvent extraction to produce ultra-high-purity alumina for batteries. This kind of policy attention rewards chemical suppliers who can demonstrate reliable Australian capability and secure supply. If you supply into critical minerals, battery materials or advanced manufacturing, make it easy for a buyer to see which approvals you hold and how you protect supply continuity — that is not something a buyer can quickly recreate by building a new plant.

Agricultural sector demand for agrichemicals and fertilisers

ABARES forecasts Australia's combined agriculture, fisheries and forestry production will reach a record $101.6 billion in 2025-26, with fertiliser costs also projected to rise as growing conditions improve in some cropping regions. The Australian crop protection market is estimated at around $1.6-1.7 billion in 2025-26 and growing steadily, underpinned by the fact that roughly 70% of Australian farm output is exported, creating constant pressure to manage weeds, pests and disease. For an owner in agricultural chemical formulation, registration or distribution, this is a genuinely supportive backdrop — but buyers will still want to see product registrations, grower relationships and a diversified customer base rather than exposure to one crop or region.

Construction and infrastructure demand for paints, coatings and adhesives

The Housing Industry Association expects home building to strengthen through 2026, with apartment and multi-unit starts forecast to rise as the sector recovers from a sluggish cycle. The Australian paints and coatings market is estimated at around $3.0 billion, growing steadily, while the adhesives and sealants segment is tracking similar growth tied to construction activity. Rising tender price indices also flow through to higher-value demand for coatings and building-chemical inputs even before volume growth is accounted for. Owners in paints, coatings or adhesives manufacturing should track how much of their revenue is tied to new construction versus maintenance and repainting work, since the latter tends to be more resilient through a construction cycle.

Regulatory change: AICIS, PFAS and APVMA compliance costs

From 1 September 2026, AICIS is restructuring its fee model, and the scheme's categorisation guidelines have also been revised. Separately, the 1 July 2025 ban on PFOA, PFOS and PFHxS "forever chemicals" is requiring manufacturers and importers across coatings, cleaning products and industrial chemicals to review reformulation exposure. The APVMA is also transitioning to a new funding model that shifts more cost toward new-product registrants. These recurring compliance obligations weigh proportionally more heavily on smaller manufacturers than on scaled players, which is a classic driver of consolidation. Owners who can show a business is already compliant, with current registrations and low legacy-chemical exposure, present a materially lower-risk proposition to a buyer than one with unresolved regulatory questions.

Supply chain reshoring and import replacement

Global supply shocks have repeatedly exposed Australia's reliance on imported chemical inputs. In 2026, China moved to restrict exports of sulphuric acid — the world's most-used industrial chemical — leaving Australian manufacturers weighing stockpiling against reformulation. This follows Nufarm's 2020 closure of local crop protection manufacturing and the 2022 fertiliser price shock triggered by the Russia-Ukraine war's impact on potash and ammonia feedstock. For a business owner, secure or diversified supply arrangements are increasingly a genuine point of differentiation buyers will ask about directly, not just an operational detail.

Sustainability, decarbonisation and the circular economy

Australia's chemicals and plastics sub-sector accounts for close to 18% of manufacturing energy use, making decarbonisation a material cost lever. Orica's $432 million Hunter Valley green hydrogen hub, backed by significant government funding, illustrates the scale of investment now flowing into lower-carbon chemical production. On the circular economy side, mandatory packaging reforms are targeting recycled content, recyclability labelling and a phase-out of harmful chemicals in packaging. Owners whose products already meet emerging sustainability and packaging standards are better positioned as these reforms tighten, since retrofitting compliance later is more expensive than building it in now.

Labour and technical skills availability

The Australian chemistry industry directly supports more than 62,500 full-time jobs, and the sector's peak body has identified experienced chemists, chemical engineers and production and plant engineers as occupations in short supply. This labour constraint raises the value of a business with a genuinely capable second line of management, because a buyer knows technical talent is difficult and slow to replace. If your business relies heavily on one experienced formulator, chemist or plant manager, start documenting processes and cross-training earlier rather than later — succession risk at the technical level is something buyers will test closely.

Private equity and strategic buyer activity

Australian chemical distribution and manufacturing assets have a long history of private equity and strategic buyer interest, from Blackstone and Keppel Infrastructure Trust's ownership of Ixom to more recent bolt-on activity by Azelis, Redox and DGL Group. Globally, industry commentary notes that private equity investment in the chemical sector has become more selective heading into 2026, with sponsors favouring acquisitions offering steady, predictable cash flow over speculative growth bets. For a mid-market Australian seller, this points toward one clear priority: stable, well-documented earnings are more attractive to today's buyer pool than a fast-growing but thin-margin operation.

Energy costs and input price volatility

Energy cost pressure is one of the most consistently cited constraints on Australian chemical manufacturing profitability. Analysis cited by industry commentators shows natural gas input costs for manufacturing have risen 186% since 2000, with chemicals and minerals processing named among the most exposed subsectors during the 2022 energy price shock. Energy-intensive, sub-scale chemical operators are structurally disadvantaged relative to larger players who can better absorb or hedge input cost volatility. If your business has any exposure to gas or electricity-intensive processes, having a clear energy contract and hedging strategy documented will materially reduce a buyer's perceived risk.

Broader Australian M&A market conditions heading into 2026

Multiple independent deal-advisory sources converge on a consistent theme: the Australian mid-market is outperforming the broader M&A market heading into 2026. Mid-market deal values rose 14% in 2025 to roughly $20.9 billion, dealmaker confidence has recovered sharply from historic lows, and 42% of dealmakers now cite succession planning as the top driver of 2026 deal activity — precisely the segment Morgan Business Sales serves. Inbound foreign investment has also risen sharply, widening the buyer pool for Australian owners across every sector, chemicals included.

2026 Market Outlook: Timing, Trends, and Opportunities

2026 is a sensible time for chemical manufacturing business owners to assess their options, particularly where succession is on the horizon. Mid-market deal appetite is genuinely stronger than the broader Australian M&A market, and demand tailwinds from critical minerals processing, agriculture, construction and reshoring all support ongoing buyer interest in this sector. This does not mean every owner should rush to market. It means there is real value in preparing early enough to choose the timing, address any regulatory gaps and approach more than one type of buyer.

The businesses receiving the strongest attention tend to share several features: dependable, well-documented earnings rather than one-off project revenue; a customer base that is not dominated by one account or one crop cycle; clean regulatory and environmental compliance, particularly around PFAS and chemical registrations; secure or diversified input supply; and a management team that can keep the business running without the founder handling every technical decision. None of these are abstract. They are the specific items a buyer's due diligence team will test before deciding how much cash to offer at completion and how much to defer.

There are genuine headwinds too. Energy costs remain a structural pressure on margins, particularly for gas- or electricity-intensive processes. Regulatory compliance costs are rising, especially around AICIS fee changes and the PFAS phase-out. Global private equity appetite for chemicals specifically has become more selective, favouring stable cash generators over growth stories. Skilled formulators, chemists and process engineers remain difficult to hire and retain. The most practical response to all of this is the same: prepare clean monthly accounts, document your regulatory position clearly, address any legacy chemical or environmental exposure ahead of time, and build management depth beyond the founder. That preparation lets you decide whether to sell now, grow toward a later sale, or pursue a partial exit from a position of knowledge rather than urgency.

Key Operators

These businesses show the scale of active strategic buyers and major sector participants. The revenue figures provide context only; they are not valuation benchmarks for a private business.

What Drives Value in Chemical Manufacturing Businesses

Recurring and Contracted Revenue

Buyers place more confidence in earnings they can see continuing after settlement. In chemical manufacturing and distribution, that can include long-standing supply agreements, repeat B2B orders, exclusive distribution rights and contracted maintenance-chemical or agricultural-input relationships that renew year after year. One-off project or seasonal sales are not a weakness on their own, but they are harder to forecast and usually attract more scrutiny. Start separating recurring, repeat and one-off revenue in your management accounts, and be ready to explain how long key supply relationships have run and what would happen to them if you stepped back. The clearer that picture, the easier it is for a buyer to pay for future earnings rather than only the last financial year.

Customer Concentration and Diversification

A long relationship with a major customer, distributor or supplier can be a genuine strength, but a business that depends heavily on one customer, one crop type, or one supplier for a critical raw material is riskier to buy. Buyers will look at the percentage of revenue and profit held by each customer, contract terms, and who within the business owns each relationship. The goal is not to abandon strong existing relationships. It is to show a stable base, a realistic pipeline of new business, and more than one source of both customers and critical inputs. Owners can improve this well before a sale by tracking account-level profitability and broadening supplier and customer relationships across the wider team.

Regulatory Registrations and Compliance

Product registrations, AICIS listings, TGA approvals, APVMA registrations and demonstrated PFAS-free formulations can be genuinely difficult for a buyer to replicate quickly. They show the business has already cleared the regulatory hurdles needed to sell into demanding categories. Keep registration certificates current, document any reformulation work already completed ahead of regulatory deadlines, and be transparent about legacy chemical exposure rather than letting a buyer discover it during diligence. A business with a clean, well-documented compliance file reduces perceived risk for a buyer and can materially shorten the due diligence process.

Formulation Know-How and Intellectual Property

In chemical manufacturing, a large part of a business's value often sits in formulation knowledge that may not be formally documented anywhere. Buyers want reassurance that this knowledge exists in written processes, quality-control documentation and formulation records — not only in one chemist's head. Where possible, document formulations, raw-material specifications, quality-testing procedures and any proprietary processes clearly enough that a new technical hire could pick up the work. This kind of documentation is one of the most effective ways to reduce a buyer's perceived key-person risk in a technical manufacturing business.

Management Depth and Founder Independence

A chemical manufacturing or distribution business is worth more when it can keep operating smoothly after the owner steps back. If the founder is also the lead chemist, the main point of contact for every major customer, and the only person who understands the regulatory position, a buyer will see meaningful risk. The answer is not for the founder to disappear overnight — it is to build a capable second line of technical and commercial staff, document how the business operates day to day, and share customer and supplier relationships more broadly across the team well before a sale process begins. Buyers are generally comfortable with a sensible handover period; they are far less comfortable when there is no business without the founder in the room.

Frequently Asked Questions

Sources

1. Australian Bureau of Statistics — ANZSIC 2006 detailed classification, Division C Manufacturing
2. Chemistry Australia — Economic contribution of the chemistry industry (A$48-49bn GDP, ~70,000 direct jobs)
3. Chemistry Australia — Jobs and skills in the chemistry industry (62,500+ FTE jobs)
4. NZX — DGL Group acquisition of Aquapac Pty Ltd announcement
5. ASX — DGL Group acquisition of RLA Polymers NZ (Bondlast) announcement
6. ShawKwei & Partners — Rauxel Pty Ltd acquisition announcement
7. Market Index — DGL Group Aquadex acquisition announcement
8. Australian Manufacturing — DGL Group acquisition of Flexichem Australia
9. Fuels and Lubes Asia — Azelis acquisition of Chemiplas Agencies
10. DGL Group — Enlog Pacific Holdings ASX release (2.5x EBITDA disclosed)
11. IMCD N.V. — ResChem Technologies acquisition announcement
12. Azelis — Agspec Australia acquisition announcement
13. Listcorp — DGL Group acquisition of Australian Petro Chemical Storage
14. Christeyns — True Blue Chemicals joint venture announcement
15. Redox Limited — Molekulis acquisition announcement
16. Small Caps — De.mem Limited acquisition of Core Chemicals
17. Medianet — HydroChem and Environex transaction announcement
18. ION Analytics/Mergermarket — Fortitude Investment Partners acquisition of Richard Jay
19. Woollahra Group — Surekleen Product Sales acquisition announcement
20. Lawyers Weekly — IXOM acquisition of Australian Botanical Products
21. Pental — Sale of Pental Consumer Products to Selleys/DuluxGroup
22. Private Equity Media — VidaCorp acquisition of Nude by Nature and Makeup Cartel
23. Thaddeus Martin — Glow Capital Partners acquisition of Delta Laboratories
24. Gasworld — Nippon Sanso acquisition of Coregas
25. Elders Limited — Delta Agribusiness acquisition announcement
26. ASX — Ridley Corporation acquisition of Incitec Pivot Fertilisers Distribution business
27. Business News Australia — Ridley/Incitec Pivot Fertilisers deal (5.0x EBITDA disclosed)
28. Veolia — Enviropacific acquisition announcement
29. Keppel Infrastructure Trust — Ixom acquisition announcement (8.2x EV/EBITDA disclosed)
30. Grant Thornton Australia — Dealtracker 2025 (SME EV/EBITDA benchmark data)
31. National Reconstruction Fund Corporation — Resources priority area
32. National Reconstruction Fund Corporation — Alpha HPA investment announcement
33. Department of Agriculture, Fisheries and Forestry — ABARES September 2025 reports (record farm production forecast)
34. Mordor Intelligence — Australia crop protection (pesticides) market report
35. Housing Industry Association — Home building outlook 2026
36. Expert Market Research — Australia paints and coatings market report
37. Research and Markets — Adhesives and sealants in Australia report
38. GPC Gateway — AICIS 2026-27 fee changes announcement
39. Clayton Utz — PFAS ban analysis for Australian businesses
40. Minister for Agriculture — APVMA funding and sustainable funding policy media release
41. ABC News — China's 2026 sulphuric acid export restrictions
42. Australian Financial Review — Nufarm's 2020 domestic manufacturing closures
43. ChemAnalyst — Orica's Hunter Valley green hydrogen hub announcement
44. Department of Climate Change, Energy, the Environment and Water — Chemicals and plastics manufacturing sector guide
45. Jobs and Skills Australia — Chemistry Australia submission on skills shortages
46. C&EN (American Chemical Society) — Private equity investors regroup in the chemical sector
47. MacroBusiness — Analysis of Australian manufacturing energy costs
48. Australian Industry Group — Snapshot of impacts of the 2022 energy price shock on Australian industry
49. PwC Australia — M&A Outlook 2026
50. ION Analytics/Mergermarket — Australian M&A Outlook 2026 (42% cite succession as top driver)
51. EAC Partners — M&A Insight, The Strategic Inflection Point, April 2026
52. Gadens — Australian M&A Review, February 2026
53. William Buck — Dealmaking Insights Report 2026
54. Morgan Business Sales — 2025 Australian Manufacturing M&A Report
55. Morgan Business Sales — Book a confidential consultation

Disclaimer: This report has been prepared by Morgan Business Sales for general information purposes only. It does not constitute financial, legal, or investment advice. Transaction values, multiples, and market data are sourced from publicly available information and third-party research. Actual outcomes vary depending on individual business characteristics, market conditions, and negotiated terms. Readers should seek independent professional advice before making any business or investment decisions. Morgan Business Sales is not responsible for decisions made based on information contained in this report.